Who is the CEO of AstraZeneca?

Pascal Soriot, since 2012, as the AsOf record states with its sources.

Record

AstraZeneca as of November 8, 2025 · AsOf

organization

AstraZeneca

AstraZeneca is a British-Swedish pharmaceutical company, headquartered in Cambridge. Its CEO is Pascal Soriot, since 2012. It reported revenue of $54.07B for the period ended December 31, 2024.

CEO: Pascal Soriot since 2012 astrazeneca.com
Headquarters: Cambridge sec.gov
Revenue: $54.07B to 2024-12-31 sec.gov
Ticker: AZN · NYSE sec.gov

Read the record as of a date

Compare the record on two dates →

State as of 2025-11-08

1 assertedThe record stands behind this value for the day asked: two independent sources agree, or a primary source states it (alone, at confidence 0.7 or more). Everything else stays on the record, labelled.More in About → fact

AstraZeneca: state as of 2025-11-08, one row per fact with its value, date, confidence and sources
fact	value	valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →	confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →	sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →

Latest

0 dated events · full timeline →

No dated events on the record yet.

Releases, deals, appointments and policy changes land here once a checked source dates them.

Every claim on the timeline, including undated ones →

Financials

latest period on record · change vs prior year

Revenue

$54.07B

2024-12-31+18.0%

every revenue figure →

Net income

$7.04B

2024-12-31+18.1%

every net income figure →

Operating income

$10.00B

2024-12-31+22.1%

every operating income figure →

Total assets

$104.03B

2024-12-31+2.9%

As reported in the linked filings, which may be restated. Not investment advice.

State changes since 2025-05-12

0 changes

No changes since 2025-05-12.

Widen the window with the since date, or compare two dates with the diff.

The full timeline →

About this record

Identifiers7 keys · schema.org snippet

AsOf ID: ent_astrazeneca
Wikidata: Q731938
SEC CIK: 0000901832
fiscal year end: 12-31
SIC industry: Pharmaceutical Preparations (2834)
incorporated in: X0
ticker: AZN

Cite this record in schema.org

"sameAs": ["https://www.wikidata.org/wiki/Q731938", "https://asof.is/record/astrazeneca"],
"identifier": { "@type": "PropertyValue", "propertyID": "asof", "value": "ent_astrazeneca" }

Paste into the entity's JSON-LD. Why and how.

Sources on this entity3 sites · 68 citations

sec.govprimary · 66
astrazeneca.comprimary · 1
wikidata.orgsecondary · 1

66 claims on record, 14 currently valid, 52 superseded. Last change 2024-12-31.